Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for May 29th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 29th:

BioLineRx Ltd. : This clinical stage biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.1% over the last 60 days.

BioLineRx Ltd. Price and Consensus

BioLineRx's shares gained 9.2% over the last one month compared to S&P 500’s rise of 5.5%. The company possesses a Momentum Score of A.

BioLineRx Ltd. Price

Gold Standard Ventures Corp : This gold-bearing mineral resource exploration stage company, has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.

Gold Standard Ventures Corporation Price and Consensus

Gold Standard’s shares gained 7.7% over the last one month. The company possesses a Momentum Score of A.

Gold Standard Ventures Corporation Price

Nutanix, Inc. (NTNX - Free Report) : This developer and provider of an enterprise cloud platform has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.

Nutanix Inc. Price and Consensus

Nutanix's shares gained 25.1% over the last one month. The company possesses a Momentum Score of A.

Nutanix Inc. Price

Alexco Resource Corp. : This company that is engaged in mineral exploration, and mine development and operational activities has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Alexco Resource Corp Price and Consensus

Alexco's shares gained 41% over the last one month. The company possesses a Momentum Score of A.

Alexco Resource Corp Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


BioLineRx Ltd. (BLRX) - free report >>

Nutanix (NTNX) - free report >>

Published in